Gyre Therapeutics
GYRE
#5620
Rank
NZ$1.69 B
Marketcap
$19.70
Share price
4.50%
Change (1 day)
-58.21%
Change (1 year)

EPS for Gyre Therapeutics (GYRE)

EPS in 2024 (TTM): $0.18

According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.49. In 2023 the company made an earnings per share (EPS) of -$2.49 a decrease over its 2022 EPS that were of $0.007709.

EPS history for Gyre Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)$0.18-107.05%
2023-$2.49-32451.8%
2022$0.007709-90.93%
2021$0.08494